p53-independent functions of the p19(ARF) tumor suppressor

Jason D. Weber, John R. Jeffers, Jerold E. Rehg, David H. Randle, Guillermina Lozano, Martine F. Roussel, Charles J. Sherr, Gerard P. Zambetti

Research output: Contribution to journalArticlepeer-review

336 Scopus citations


The p19(ARF) tumor suppressor antagonizes Mdm2 to induce p53-dependent cell cycle arrest. Individual TKO (triple knock out) mice nullizygous for ARF, p53, and Mdm2 develop multiple tumors at a frequency greater than those observed in animals lacking both p53 and Mdm2 or p53 alone, demonstrating that p19(ARF) can act independently of the Mdm2-p53 axis in tumor surveillance. Reintroduction of ARF into TKO mouse embryo fibroblasts (MEFs), but not into those lacking both p53 and ARF, arrested the cell division cycle in the G1 phase. Inhibition of the retinoblastoma protein had no effect on the ability of ARF to arrest TKO MEFs. Thus, in the absence of Mdm2, p19(ARF) interacts with other targets to inhibit cell proliferation.

Original languageEnglish
Pages (from-to)2358-2365
Number of pages8
JournalGenes and Development
Issue number18
StatePublished - Sep 15 2000


  • ARF
  • DMP1
  • Mdm2
  • Tumor suppression
  • p53


Dive into the research topics of 'p53-independent functions of the p19(ARF) tumor suppressor'. Together they form a unique fingerprint.

Cite this